These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2595587)

  • 1. [Characteristics of the action of modified atherogenic-class lipoproteins on the functional activity of peripheral blood lymphocytes in patients with ischemic heart disease].
    Vasil'chenko EM; Beĭko VA; Karpov RS; Kanskaia NV
    Ter Arkh; 1989; 61(9):56-9. PubMed ID: 2595587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peculiarities of interactions of bilayer lipid membranes with human plasma lipoproteins from patients with ischemic heart disease].
    Tverdislov VA; Martseniuk OV; El'-Karadagi S; Perova NV; Gerasimova EN
    Biofizika; 1982; 27(1):164-5. PubMed ID: 7066391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
    Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
    Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlated biochemical modifications of plasma lipoproteins in coronary heart disease: an accelerating pathologic factor.
    Sima A; Hobai I; Stancu C; Cinteză M; Gherasim L
    Rom J Intern Med; 1996; 34(1-2):55-64. PubMed ID: 8908631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
    Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
    Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very low density lipoprotein hematopoiesis inhibitor from rat plasma.
    Zucker S; Lysik RM; Chikkappa G; Glucksman MJ; Gomez-Reino J; DiStefano JF
    Exp Hematol; 1980 Aug; 8(7):895-905. PubMed ID: 16398021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thymalin on the development of experimental hyperlipidemia and atherosclerosis].
    Ryzhenkov VE; Ogurtsov RP; Trubacheva VV; Popov VG; Puzyreva VP
    Vopr Med Khim; 1988; 34(1):51-6. PubMed ID: 2967015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 11. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat hematopoietic cell receptors for very low density lipoprotein (VLDL) growth inhibitor.
    Zucker S; Beck G; Yi P; Lysik RM; DiStefano JF
    Exp Hematol; 1981 May; 9(5):550-62. PubMed ID: 7238661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexamethasone on migration of human monocytes in response to oxidized beta-very low density lipoprotein.
    Yamada K; Naito M; Hayashi T; Asai K; Yoshimine N; Iguchi A
    Artery; 1993; 20(5):253-67. PubMed ID: 8141646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the structural organization of lipoproteins in the blood plasma of patients with ischemic heart disease using the spin probe method].
    Panasenko OM; Azizova OA; Torkhovskaia TI; Dudaev VA
    Vopr Med Khim; 1984; 30(6):40-5. PubMed ID: 6098993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 response to arterial antigen, lipopolysaccharide, and oxidized low density lipoprotein in ischemic heart disease.
    Grasing K; Rifici V; Patel M; Patel A; Dennis R; Kostis JB
    J Investig Med; 1997 Oct; 45(8):474-82. PubMed ID: 9394101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis.
    Schwandt P
    Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein abnormalities in non-insulin dependent diabetic patients with ischemic heart disease.
    Murakami T; Yamada N; Kawakubo K; Oku J; Mizushima Y; Iino S; Sugimoto T
    Artery; 1997; 22(4):206-32. PubMed ID: 9576026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
    Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
    Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.